Who owns Gossamer Bio Inc?
- Ticker: GOSS
- CUSIP Number: 38341p102
Tip: Access positions for across all investors
Analyze quarterly positions in Gossamer Bio with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Gossamer Bio stock
Who bought or sold Gossamer Bio Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Octagon Capital Advisors | 18M | $20M | 0% | Mar 2025 |
|
| NEA Management Company | 18M | $20M | 0% | Mar 2025 |
|
| Vanguard Group | 10M | $11M | 0% | Mar 2025 |
|
| Arch Venture Corp | 8.1M | $8.8M | 0% | Mar 2025 |
|
| FMR | 7.6M | $8.4M | -4% | Mar 2025 |
|
| Acadian Asset Management | 6.4M | $7.0M | 25% | Mar 2025 |
|
| Palo Alto Investors | 6.3M | $6.9M | 0% | Mar 2025 |
|
| 683 Capital Management | 6.1M | $6.7M | -13% | Mar 2025 |
|
| Siren | 5.2M | $5.7M | -4% | Mar 2025 |
|
| Hillhouse Capital Advisors | 5.0M | $5.5M | 0% | Mar 2025 |
|
| Monaco Asset Management SAM | 4.8M | $5.3M | -10% | Mar 2025 |
|
| Opaleye Management | 4.3M | $4.7M | -5% | Mar 2025 |
|
| Alyeska Investment Group | 4.2M | $4.6M | -53% | Mar 2025 |
|
| Eversept Partners | 3.9M | $4.3M | -22% | Mar 2025 |
|
| Susquehanna International | 3.9M | $4.3M | 220% | Mar 2025 |
|
| CI Private Wealth | 3.4M | $3.7M | 0% | Mar 2025 |
|
| Rock Springs Capital Management | 3.3M | $3.6M | 0% | Mar 2025 |
|
| BlackRock | 3.1M | $3.4M | 1% | Mar 2025 |
|
| Millennium Management | 2.7M | $2.9M | -25% | Mar 2025 |
|
| Geode Capital Management | 2.3M | $2.5M | 1% | Mar 2025 |
|
| Deutsche Bank Aktiengesellschaft | 2.1M | $2.3M | 0% | Mar 2025 |
|
| Platinum Investment Mangement | 1.7M | $1.9M | -46% | Mar 2025 |
|
| Marshall Wace | 1.7M | $1.9M | -32% | Mar 2025 |
|
| Renaissance Technologies | 1.6M | $1.7M | -8% | Mar 2025 |
|
| Laurion Capital Management | 1.6M | $1.7M | 4% | Mar 2025 |
|
| Two Sigma Advisers | 1.3M | $1.4M | 11% | Mar 2025 |
|
| Two Sigma Investments | 1.3M | $1.4M | 43% | Mar 2025 |
|
| Charles Schwab Investment Management | 1.1M | $1.3M | -8% | Mar 2025 |
|
| Exome Asset Management | 1.1M | $1.2M | 0% | Mar 2025 |
|
| Goldman Sachs Group | 940k | $1.0M | 720% | Mar 2025 |
|
| DAFNA Capital Management | 908k | $999k | -36% | Mar 2025 |
|
| Qube Research & Technologies | 896k | $985k | 29% | Mar 2025 |
|
| State Street Corporation | 883k | $971k | 15% | Mar 2025 |
|
| Arrowstreet Capital, Limited Partnership | 804k | $884k | 100% | Mar 2025 |
|
| Colony | 700k | $770k | 100% | Mar 2025 |
|
| GSA Capital Partners | 696k | $765k | -19% | Mar 2025 |
|
| Jane Street | 683k | $752k | 5250% | Mar 2025 |
|
| Bridgeway Capital Management | 561k | $617k | 4% | Mar 2025 |
|
| Highbridge Capital Management | 498k | $548k | -17% | Mar 2025 |
|
| Northern Trust | 410k | $452k | 0% | Mar 2025 |
|
| Hrt Financial | 390k | $428k | 100% | Mar 2025 |
|
| Springbok Capital Management | 377k | $415k | -9% | Mar 2025 |
|
| Mackenzie Financial | 353k | $388k | 18% | Mar 2025 |
|
| OMERS Administration Corporation | 352k | $387k | 100% | Mar 2025 |
|
| Silverback Asset Management | 350k | $385k | 100% | Mar 2025 |
|
| Smith, Moore & Co. | 300k | $330k | 0% | Mar 2025 |
|
| Balyasny Asset Management | 289k | $318k | 100% | Mar 2025 |
|
| Citadel Advisors | 283k | $311k | -18% | Mar 2025 |
|
| Jacobs Levy Equity Management | 282k | $311k | -82% | Mar 2025 |
|
| Victory Capital Management | 264k | $291k | 0% | Mar 2025 |
|
| Barclays | 245k | $270k | 245000% | Mar 2025 |
|
| ADAR1 Capital Management | 227k | $250k | -28% | Mar 2025 |
|
| UBS Group | 220k | $242k | 1057% | Mar 2025 |
|
| Squarepoint Ops | 218k | $240k | 203% | Mar 2025 |
|
| Group One Trading | 208k | $229k | 178% | Mar 2025 |
|
| Schonfeld Strategic Advisors | 202k | $222k | 30% | Mar 2025 |
|
| Caption Management | 200k | $220k | 100% | Mar 2025 |
|
| Jain Global | 200k | $220k | 100% | Mar 2025 |
|
| Cubist Systematic Strategies | 194k | $213k | 100% | Mar 2025 |
|
| Birchview Capital | 138k | $152k | 0% | Mar 2025 |
|
| Sequoia Financial Advisors | 119k | $130k | 0% | Mar 2025 |
|
| LMR Partners | 116k | $127k | 100% | Mar 2025 |
|
| Leucadia National Corporation | 100k | $110k | 0% | Mar 2025 |
|
| Diametric Capital | 96k | $106k | -57% | Mar 2025 |
|
| Point72 Asia | 83k | $91k | 100% | Mar 2025 |
|
| Financial Advocates Investment Management | 79k | $87k | 0% | Mar 2025 |
|
| Velan Capital Investment Management | 75k | $83k | 0% | Mar 2025 |
|
| Catalyst Funds Management Pty | 52k | $57k | 100% | Mar 2025 |
|
| Rsm Us Wealth Management | 48k | $53k | 0% | Mar 2025 |
|
| Prudential Financial | 47k | $52k | 0% | Mar 2025 |
|
| HB Wealth Management | 47k | $51k | 24% | Mar 2025 |
|
| Tudor Investment Corporation | 47k | $51k | 0% | Mar 2025 |
|
| Lazard Asset Management | 44k | $48k | -59% | Mar 2025 |
|
| Invesco | 44k | $48k | 100% | Mar 2025 |
|
| Commonwealth Equity Services | 42k | $46k | 22% | Mar 2025 |
|
| Hudson Bay Capital Management | 37k | $41k | 100% | Mar 2025 |
|
| Virtu Financial | 35k | $38k | 100% | Mar 2025 |
|
| Us Bancorp | 34k | $37k | -16% | Mar 2025 |
|
| Sivia Capital Partners | 30k | $37k | 0% | Jun 2025 |
|
| Callan Capital | 30k | $32k | -40% | Mar 2025 |
|
| Graham Capital Management | 29k | $32k | -17% | Mar 2025 |
|
| Advisor Group Holdings | 28k | $30k | 0% | Mar 2025 |
|
| Silvercrest Asset Management Group | 26k | $29k | 0% | Mar 2025 |
|
| Brevan Howard Capital Management | 24k | $26k | 100% | Mar 2025 |
|
| Traynor Capital Management | 23k | $26k | 66% | Mar 2025 |
|
| Hartland & Co | 22k | $24k | 0% | Mar 2025 |
|
| Bank of New York Mellon | 20k | $22k | 0% | Mar 2025 |
|
| Cambridge Investment Research Advisors | 19k | $21k | 21% | Mar 2025 |
|
| Wolverine Trading | 19k | $22k | -65% | Mar 2025 |
|
| Drive Wealth Management | 17k | $18k | 100% | Mar 2025 |
|
| CTC Alternative Strategies | 17k | $18k | 100% | Mar 2025 |
|
| Jpmorgan Chase & Co | 16k | $17k | 204% | Mar 2025 |
|
| HPM Partners | 14k | $15k | 100% | Mar 2025 |
|
| Point72 | 13k | $14k | 100% | Mar 2025 |
|
| Moors & Cabot | 11k | $12k | 10% | Mar 2025 |
|
| Rialto Wealth Management | 11k | $12k | 0% | Mar 2025 |
|
| Citigroup | 11k | $11k | 355833% | Mar 2025 |
|
| Yale Capital Corp. | 10k | $11k | 0% | Mar 2025 |
|
| Tower Research Capital | 5.1k | $5.6k | 100% | Mar 2025 |
|
| Wells Fargo & Company | 4.4k | $4.8k | 100% | Mar 2025 |
|
| SBI Securities | 1.1k | $1.2k | -88% | Mar 2025 |
|
| Steward Partners Investment Advisory | 1.0k | $1.1k | 0% | Mar 2025 |
|
| Bnp Paribas Arbitrage, Snc | 919.00 | $1.0k | -4% | Mar 2025 |
|
| Royal Bank of Canada | 766.00 | $1.0k | -49% | Mar 2025 |
|
| Federation des caisses Desjardins du Quebec | 750.00 | $825.000000 | 0% | Mar 2025 |
|
| PFS Partners | 50.00 | $55.000000 | -21% | Mar 2025 |
|
| Morton Brown Family Wealth | 25.00 | $28.000000 | 0% | Mar 2025 |
|
| Capital Advisors | 17.00 | $0 | 0% | Mar 2025 |
|
Who sold out of Gossamer Bio?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Fullcircle Wealth | Dec 2024 | 48k | $63k |
| Cetera Investment Advisers | Dec 2024 | 25k | $23k |
| Stephenson National Bank & Trust | Dec 2024 | 25k | $23k |
| XTX Topco | Dec 2024 | 21k | $19k |
| Farther Finance Advisors | Dec 2024 | 400.00 | $362.000000 |